Marcel Borgers

Corporate Officer/Principal presso Université Libre de Bruxelles

84 anni

Consumer Services

Health Technology

Posizioni attive di Marcel Borgers

Società	Posizione	Inizio	Fine
Université Libre de Bruxelles	Corporate Officer/Principal	01/01/1994	-
Maastricht University	Corporate Officer/Principal	01/01/1991	-

Società	Posizione	Inizio	Fine
University of Antwerp	Corporate Officer/Principal	01/01/1992	01/01/2002
The Janssen Research Foundation	Corporate Officer/Principal	01/09/1969	01/04/2000
Barrier Therapeutics, Inc. Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ	Direttore Tecnico/Scientifico/R&S	-	-

Université Paris 1 Panthéon-Sorbonne

Doctorate Degree

Distribuzione geografica

Posizioni

Corporate Officer/Principal	4
Chief Tech/Sci/R&D Officer	1
Doctorate Degree	1

Settori

Consumer Services	5
Health Technology	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	2
Barrier Therapeutics, Inc. Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ	Health Technology
The Janssen Research Foundation

Aziende private

Health Technology

The Janssen Research Foundation